Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biol
2003 Dec 01;2323:8795-808. doi: 10.1128/MCB.23.23.8795-8808.2003.
Show Gene links
Show Anatomy links
Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties.
Segalla S
,
Rinaldi L
,
Kilstrup-Nielsen C
,
Badaracco G
,
Minucci S
,
Pelicci PG
,
Landsberger N
.
???displayArticle.abstract???
PML-RAR is an oncogenic transcription factor forming in acute promyelocytic leukemias (APL) because of a chromosomal translocation. Without its ligand, retinoic acid (RA), PML-RAR functions as a constitutive transcriptional repressor, abnormally associating with the corepressor-histone deacetylase complex and blocking hematopoietic differentiation. In the presence of pharmacological concentrations of RA, PML-RAR activates transcription and stimulates differentiation. Even though it has been suggested that chromatin alteration is important for APL onset, the PML-RAR effect on chromatin of target promoters has not been investigated. Taking advantage of the Xenopus oocyte system, we compared the wild-type transcription factor RARalpha with PML-RAR as both transcriptional regulators and chromatin structure modifiers. Without RA, we found that PML-RAR is a more potent transcriptional repressor that does not require the cofactor RXR and produces a closed chromatin configuration. Surprisingly, repression by PML-RAR occurs through a further pathway that is independent of nucleosome deposition and histone deacetylation. In the presence of RA, PML-RAR is a less efficient transcriptional activator that is unable to modify the DNA nucleoprotein structure. We propose that PML-RAR, aside from its ability to recruit aberrant quantities of histone deacetylase complexes, has acquired additional repressive mechanisms and lost important activating functions; the comprehension of these mechanisms might reveal novel targets for antileukemic intervention.
Belikov,
Hormone activation induces nucleosome positioning in vivo.
2000,
Pubmed
,
Xenbase
Benedetti,
Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
1997,
Pubmed
Bhattacharyya,
Retinoid-induced chromatin structure alterations in the retinoic acid receptor beta2 promoter.
1997,
Pubmed
Brown,
A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.
1997,
Pubmed
Chen,
Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.
1999,
Pubmed
Di Croce,
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
2002,
Pubmed
Dilworth,
ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR In vitro.
2000,
Pubmed
Dong,
Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
1996,
Pubmed
Early,
Transgenic expression of PML/RARalpha impairs myelopoiesis.
1996,
Pubmed
Fondell,
Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression.
1996,
Pubmed
Grignani,
Acute promyelocytic leukemia: from genetics to treatment.
1994,
Pubmed
Grignani,
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
1996,
Pubmed
Grignani,
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
1998,
Pubmed
He,
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
1998,
Pubmed
Huang,
A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription.
2003,
Pubmed
,
Xenbase
Landsberger,
Role of chromatin and Xenopus laevis heat shock transcription factor in regulation of transcription from the X. laevis hsp70 promoter in vivo.
1995,
Pubmed
,
Xenbase
Landsberger,
Remodeling of regulatory nucleoprotein complexes on the Xenopus hsp70 promoter during meiotic maturation of the Xenopus oocyte.
1997,
Pubmed
,
Xenbase
Lee,
Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors.
2001,
Pubmed
Lin,
Role of the histone deacetylase complex in acute promyelocytic leukaemia.
1998,
Pubmed
Lin,
Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.
2000,
Pubmed
Mangelsdorf,
The RXR heterodimers and orphan receptors.
1995,
Pubmed
Minucci,
Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
2001,
Pubmed
Minucci,
Retinoid receptor-induced alteration of the chromatin assembled on a ligand-responsive promoter in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Minucci,
Retinoid receptors in health and disease: co-regulators and the chromatin connection.
1999,
Pubmed
Minucci,
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.
2000,
Pubmed
Rachez,
The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes.
2000,
Pubmed
Urnov,
Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
2000,
Pubmed
,
Xenbase
Wong,
A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor.
1995,
Pubmed
,
Xenbase
Wong,
Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase.
1998,
Pubmed
,
Xenbase
Xu,
Coactivator and corepressor complexes in nuclear receptor function.
1999,
Pubmed
